Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level
The Clinical Effectiveness of Taiwanese Whole Grain Job's Tear on Muscle Health, Blood Glucose and Lipid Levels- a Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Background: This investigation aims to explore efficacy of Taiwanese whole grain job's tear on muscle health and blood glucose and lipid levels in community-dwelling older adults. Methods: An open-label, 16-week, randomized controlled, cross-over trial involving participants with subject complaint of slower gait or weakness or fall in last year were recruited. The intervention group consumed Taiwanese whole grain job's tear (red job's tear) or white job's tear. Assessments included laboratory tests, functional assessments, and body composition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jun 2024
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2024
CompletedFirst Submitted
Initial submission to the registry
June 21, 2024
CompletedFirst Posted
Study publicly available on registry
July 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedJuly 16, 2024
July 1, 2024
6 months
June 21, 2024
July 9, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Changes of appendicular skeletal muscle index(ASMI)
ASMI=appendicular skeletal muscle mass(kg)/(height(m)2)
0, 8, 16 week
Changes of handgrip strength
Maximal handgrip strength of dominant hand (kg)
0, 8, 16 week
Changes of gait speed
Usual gait speed measured by 6-meter walking (m/s)
0, 8, 16 week
Changes of time required to finish timed up and go(TUG) test
Changes of time required to finish timed up and go(TUG) test
0, 8, 16 week
Secondary Outcomes (6)
Changes of inflammation marker
0, 8, 16 week
Changes of insulin resistance
0, 8, 16 week
Changes of LDL
0, 8, 16 week
Changes of muscle biomarker 1
0, 8 week
Changes of muscle biomarker 2
0, 8 week
- +1 more secondary outcomes
Study Arms (3)
Taiwanese whole grain job's tear (Red job's tear)
EXPERIMENTALTaiwanese whole grain job's tear (Red job's tear)
White job's tear
ACTIVE COMPARATORWhite job's tear
Active comparator group
ACTIVE COMPARATORActive comparator group * serve as comparator group from week 0 to week 8, * assigned to red job's tear or white job's tear group from week 8 to week 16
Interventions
300cc drink made from red job's tear, 2 bottle/day from week 0 to week 8
300cc drink made from white job's tear, 2 bottle/day from week 0 to week 8
Eligibility Criteria
You may qualify if:
- People who aged 60-95 years
- Patients with following characteristics:
- feeling loss in activity detecting decline in self's walking speed. feeling tired of doing everything. having fall event in last year. People willing to follow the program and cooperate with us for following tracking.
- People who are neither vegan nor vegetarian People agree and be able to sign the informed consent.
You may not qualify if:
- People with any disease affecting their limbs, including:
- having fracture on limbs in the past 6 months having severe arthritis in the past 6 months any other whom PI recognized as weak control of their nervous system( e.g.: Parkinson's disease and stroke).
- People with intermittent limp caused by peripheral artery diseases People with weak control of mental disorder People with weak control of Cardiopulmonary disease People with weak control of Malignant tumor People with weak control of kidney diseases (eGFR \<60ml/min/1.73) People with Visual impairment and Hearing disorder which cannot help to complete the program.
- People who have underwent hormone treatment and planned to undergo hormone treatment during program session.
- Any other condition that PI recognized as not suitable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Veterans General hospital
Taipei, 112, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anchun Hwang, Doctor
Taipei Veterans General Hospital, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2024
First Posted
July 16, 2024
Study Start
June 14, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
July 16, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share